Pharmaxo Healthcare is an experienced national provider of high-quality specialist care to patients in their own home.
Established in 2010, we are committed to building our services around our patients’ needs. We work with the NHS, pharmaceutical companies, private medical providers and self-funding patients to provide clinical home care services across a wide range of therapies and conditions.
Pharmaxo Healthcare works in partnership with clinical specialists and commissioning teams to provide a smooth transfer of care for patients from hospital to home. Our services are being continuously developed and improved to keep pace with the rapidly changing and developing UK health economy. We are committed to delivering high quality, patient-centred care which provides cost efficiencies and demonstrable outcomes benefits to our customers
- Oncology and Haematology
- Immunology (including HIV)
- Pulmonary Arterial Hypertension
- Enzyme Replacement Therapy
- Rheumatoid Arthritis
- Human Growth Hormone
- Cystic Fibrosis
Clinical governance remains at the centre of the NHS’s drive to ensure provider organisations are accountable for continuously monitoring and improving the quality of their care and services and safeguarding high standards. At Pharmaxo Healthcare patient safety is at the core of everything we do.
Good clinical governance ensures that Pharmaxo Healthcare delivers care of the highest standards of safety and quality to our patients. This ethos underpins our organisation’s culture, systems, and the working practices of our staff.
As a home care service provider, Pharmaxo Healthcare is regulated by:
- The Medicines and Healthcare products Regulatory Agency (MHRA)
- The General Pharmaceutical Council (GPhC)
- The Care Quality Commission (CQC)
In addition, Pharmaxo Healthcare also maintains voluntary quality management accreditation through ISO (9001:2008). We are also a member of the National Clinical home care Association (NCHA), which represents UK businesses who provide medical supplies and/or clinical services directly to patients in the community.